MRK
CALLS ▲Merck & Co., Inc.
$149.52
+2.18%delayed
News – · Trend ▲ · above call trigger ▲
Expected move (1d)
▼ $144.91to$154.13 ▲
ATR ±$4.61 (+3.08%)Implied ±$5.46 (+3.66%)
Entry Reference
Price / prev close$149.52 / $146.33
Day range$147.43 – $151.35
52-wk range$82.01 – $156.92(90%)
Volume vs avg1.19×
ATR (14d)$4.61
MA 8 / 21$145.20 / $144.57
MA 50 / 200$146.86 / $126.71
Call ▲ / Put ▼ trigger$147.42 / $145.24
+1 / +2 ATR$154.13 / $158.73
-1 / -2 ATR$144.91 / $140.31
Support: 145.75 142.32 138.80
Resistance: 152.80 153.57 156.92
Near-the-money contracts
exp 2026-11-06Calls
| Strike | Mark | IV | Δ | θ/day | OI |
|---|---|---|---|---|---|
| 146 | $5.07 | 44% | 0.68 | -0.26 | 45 |
| 147 | $4.45 | 43% | 0.63 | -0.26 | 470 |
| 148 | $3.75 | 41% | 0.59 | -0.26 | 148 |
| 149 | $3.17 | 40% | 0.54 | -0.25 | 47 |
| 150 | $2.55 | 36% | 0.49 | -0.23 | 503 |
| 152.5 | $1.56 | 35% | 0.35 | -0.21 | 211 |
Puts
| Strike | Mark | IV | Δ | θ/day | OI |
|---|---|---|---|---|---|
| 146 | $1.25 | 35% | -0.29 | -0.18 | 149 |
| 147 | $1.50 | 34% | -0.34 | -0.19 | 501 |
| 148 | $1.92 | 36% | -0.40 | -0.21 | 83 |
| 149 | $2.30 | 35% | -0.45 | -0.20 | 53 |
| 150 | $2.92 | 36% | -0.51 | -0.21 | 178 |
| 152.5 | $4.13 | 34% | -0.65 | -0.18 | 208 |
Δ = delta (≈ probability ITM), θ/day = daily time decay, IV = implied vol. Greeks computed via Black-Scholes from Yahoo IV.
Recent news
- Merck (MRK) Stock Rallies As Q3 Earnings Ease Profit Squeeze5h ago
- Why Merck Stock Flew Higher on Friday7h ago
- Eli Lilly’s Next Trillion-Dollar Opportunity May Go Beyond Weight-Loss Drugs14h ago
- CMMB Celebrates New Distribution Center at the Brethren Service Center with Ribbon-Cutting Ceremony15h ago
- This week in charts: ESMO’s winners and losers15h ago
- EXEL Q3 Earnings Beat Estimates on Strong Cabometyx Sales16h ago
- $250,000 in Merck, Pfizer, UnitedHealth and AbbVie Could Pay $8,000 a Year in Dividends16h ago
- Global CRISPR Fluorescence Assays Market Report 2026 | Capitalize on 19.5% CAGR to 2030 with Thermo Fisher, Merck, QIAGEN, and Mammoth Biosciences Driving Multiplex Diagnostics17h ago
- Stock Market Today: Nasdaq Dives As Amazon, Intel Plunge On Earnings (Live Coverage)18h ago
- AZN Q3 Earnings Beat Estimates, Oncology Drugs Drive Sales Growth18h ago
- Merck Q3 Earnings Call Highlights Pipeline Progress and Raised Outlook18h ago
- Pfizer Yields Nearly 6%, but Its Dividend Exceeds Free Cash Flow. Is It Safe?19h ago
Reference data only. Not a recommendation. Greeks and expected-move figures are estimates, not certainties. You confirm all entries and contracts in TradingView and Charles Schwab.